Leptin Levels in Papillary Thyroid Cancer

The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thyroid Cancer, Papillary Adenocarcinoma Adenocarcinoma, Papillary Carcinoma Endocrine Gland Neoplasms Endocrine System Diseases Head and Neck Neoplasms Leptin Levels Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Thyroid Diseases Thyroid Neoplasms

Age range

19 year–75 year

Sex eligibility

Female

Study type

Observational

Primary location

University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

About this study

There will be three groups in this study, but 2 of the groups are part of another study so will only recruit normal controls.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Female
Age>/- 19
Not currently pregnant or lactating
Normal thyroid gland by history

Exclusion criteria

Male Gender
Pregnancy
Lactation
Age below 19
Abnormal thyroid gland by history
Abnormal thyroid gland by structure using ultrasound
Abnormal thyroid gland by function using TSH, Free T4

Treatment and study plan

Primary outcomes

evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.

Time frame: During Study

Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.

Sponsors and collaborators

Lead sponsor

University of Nebraska

Other

Registry information

Official study title

Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls

Acronym: LL-PTC

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Aug 7, 2012
Registry last updated: Sep 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed